Showing 1–12 of 33 results
-
ACTIVApatch IontoGo 12.0 – BPC-157 + NAD patch: 2,000mcg BPC-157 + 300mg NAD
ACTIVApatch IontoGo 12.0 Iontophoretic Drug Delivery System is a single-use, disposable, non-invase drug system that delivers 12.0 hours of BPC-157 (Polypetide-157) with Glutathione. It’s an extended wear patch with an average drug delivery dose of 80m-Amp*min treatment in 12 hours. ACTIVpatch IontoGo is a wireless system with a self-contained battery that is allows you to continue…
-
ACTIVApatch IontoGo 12.0 – NAD
ACTIVApatch IontoGo 12.0 Iontophoretic Drug Delivery System is a single-use, disposable, non-invasive drug system that delivers 12.0 hours of NAD. It’s an extended wear patch with an average drug delivery dose of 80m-Amp*min treatment in 12 hours. ACTIVpatch IontoGo is a wireless system with a self-contained battery that allows you to continue your life as normal,…
-
NAD+ Peptide
Injection:
200mg/mL (10mL Vial)
-
Peptide 5-Amino-1MQ
5-Amino-1MQ is a research compound that helps the body use energy more efficiently and burn fat more easily. It works by calming down an enzyme (NNMT) that slows the metabolism in people with obesity, diabetes, or aging. How it works: Boosts energy: Helps cells make and use energy better, so you feel more active. Burns…
-
Peptide AOD 9604
AOD9604 is a modified fragment of human growth hormone (hGH), specifically designed for reducing body fat and aiding in weight management. Unlike full hGH, AOD9604 selectively promotes fat breakdown (lipolysis) without affecting IGF-1 levels or causing hyperglycemia, which makes it a safer alternative for targeting obesity-related concerns. Mechanism of Action: AOD9604 works by stimulating receptors…
-
Peptide ARA-290
ARA-290 (also known as Cibinetide) is a non-erythropoietic peptide engineered from erythropoietin (EPO) that’s being studied for tissue protection, inflammation control, and neuropathic symptom relief – particularly small-fiber neuropathy in conditions like sarcoidosis or diabetes. Unlike full EPO, ARA-290 was designed to avoid stimulating red-blood-cell production, focusing instead on cytoprotection and immune modulation. Early clinical…
-
Peptide BPC 157
Injection: 2mg/mL – 5mL Vial
Oral: 500mcg – 60 capsules
-
Peptide Cerebrolysin
Injectable
200mg/mL – 10mL Vial -
Peptide CJC 1295 + Ipamorelin
Injectable: 2mg/mL – 5mL Vial
-
Peptide Dihexa
Oral:
2mg capsules (30 capsules);
5mg capsules (30 capsules);
10mg capsules (30 capsules). -
Peptide DSIP
Injectable
1mg/mL – 5mL Vial -
Peptide Epitalon
Injectable:
5mg/mL – 5mL vial
10mg/mL – 5mL vial